Molsidomine: alternative approaches to treat myocardial ischemia
RE Nitz, VB Fiedler - … The Journal of Human Pharmacology and …, 1987 - Wiley Online Library
The long‐acting antianginal drug molsidomine has been shown experimentally to reduce
myocardial infarct size when administered prior to or after cardiac insult. This is due to …
myocardial infarct size when administered prior to or after cardiac insult. This is due to …
Molsidomine: alternative approaches to treat myocardial ischemia
RE Nitz, VB Fiedler - Pharmacotherapy, 1987 - pubmed.ncbi.nlm.nih.gov
The long-acting antianginal drug molsidomine has been shown experimentally to reduce
myocardial infarct size when administered prior to or after cardiac insult. This is due to …
myocardial infarct size when administered prior to or after cardiac insult. This is due to …
Molsidomine: alternative approaches to treat myocardial ischemia.
RE Nitz, VB Fiedler - Pharmacotherapy, 1987 - europepmc.org
The long-acting antianginal drug molsidomine has been shown experimentally to reduce
myocardial infarct size when administered prior to or after cardiac insult. This is due to …
myocardial infarct size when administered prior to or after cardiac insult. This is due to …